Streptococcal Infections Clinical Trial
Official title:
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Dermatitis - an Open, Randomized, Controlled Trial
The goal of the study is to investigate, which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients (1-16 years of age) with perianal dermatitis caused by group A beta-hemolytic streptococci.
The goal of the study is to investigate, which of two antibiotic treatments - oral
penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients (1-16
years of age) with perianal dermatitis caused by group A beta-hemolytic streptococci
(GABHS). Diagnosis is based on positive perianal culture for GABHS. Informed consent will be
obtained.
The study will be performed in the region of Basel, Switzerland, in private practices of
pediatricians, general practitioners, and selected pediatric dermatologists as well as in
the out-patient departments of the University Children's Hospital Basel and the department
for dermatology of the University of Basel.
Patients (or their parents) will fill in a daily diary on signs and symptoms of disease;
furthermore, clinical investigations (inspection of the site of infection) will be performed
on enrollment (Day 1), Day 3, and at the end of treatment (Day 10).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02052973 -
Efficacy of Propolis Varnish Against Oral Biofilm
|
Phase 1/Phase 2 | |
Completed |
NCT01412801 -
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
|
Phase 2 | |
Completed |
NCT00884728 -
Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
|
N/A | |
Completed |
NCT01193920 -
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
|
Phase 1/Phase 2 | |
Completed |
NCT00169481 -
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
|
Phase 2 | |
Completed |
NCT02270944 -
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
|
Phase 2 | |
Completed |
NCT03055728 -
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis
|
||
Withdrawn |
NCT00598429 -
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
|
Phase 2 | |
Completed |
NCT01030731 -
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
|
Phase 1 | |
Completed |
NCT04100772 -
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above
|
Phase 1 | |
Completed |
NCT01118143 -
Oral Health Literacy Tailored Communication
|
N/A | |
Completed |
NCT01026740 -
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers
|
Phase 1 | |
Withdrawn |
NCT00330642 -
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study
|
N/A | |
Completed |
NCT00299663 -
Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract
|
N/A | |
Completed |
NCT00646958 -
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
|
Phase 2 | |
Completed |
NCT00514527 -
A Study for Patients With Complicated Skin and Skin Structure Infections
|
Phase 2 | |
Completed |
NCT01026636 -
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
|
Phase 1 | |
Completed |
NCT01026558 -
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
|
Phase 1 | |
Completed |
NCT01156740 -
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings
|
N/A | |
Completed |
NCT04841369 -
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)
|
Phase 3 |